Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
06 2019
Historique:
received: 25 07 2018
accepted: 22 05 2019
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 14 4 2020
Statut: ppublish

Résumé

Changes to the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) funding have led to closures of non-governmental HIV clinics with patient transfers to government-funded clinics. We sought to determine the success of transfers in South Africa using a national data source. All adults (≥18 years) on antiretroviral therapy (ART) who visited a single PEPFAR-funded hospital-based HIV clinic in Durban, South Africa from March to June 2012 were transferred to community-based clinics. Previously, we matched patient records from the hospital-based HIV clinic with National Health Laboratory Services (NHLS) Corporate Data Warehouse (CDW) data to estimate the proportion of patients with a CD4 count or viral load (VL) in the CDW during the year before transfer. As a proxy for retention in care, in this study we evaluated whether patients had a CD4 count or VL at another facility within approximately three years of transfer. Patients referred to a private doctor at transfer were excluded from the analysis. We assessed predictors (age, sex, CD4 count, VL status, ART duration and location of future care) of not having post-transfer laboratory data using Cox proportional hazards models. Of the 3893 patients referred to a government facility at transfer, 41% were male and median age was 39 years (IQR 34 to 46). There was a post-transfer CD4 count or VL from another facility for 23% of these individuals within six months, 44% within one year, 57% within two years and 61% within approximately three years. Male sex (aHR 1.20, 95% CI 1.10 to 1.31) and shorter duration on ART (<3 months, aHR 3.80, 95% CI 2.77 to 5.21; three months to one year, aHR 1.32, 95% CI 1.15 to 1.51, each compared with >1 year) were associated with not having a post-transfer record. Using data from the NHLS CDW, 61% of patients had evidence of a post-transfer laboratory record at another facility within approximately three years after closure of a large South African HIV clinic. Males and those with shorter time on ART prior to transfer were at highest risk for lacking follow-up laboratory data. As patients transfer care, national data sources can be used to evaluate long-term patient care trajectories.

Identifiants

pubmed: 31243898
doi: 10.1002/jia2.25326
pmc: PMC6595194
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25326

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH090326
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH108427
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI060354
Pays : United States

Informations de copyright

© 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

J Int AIDS Soc. 2019 Jun;22(6):e25326
pubmed: 31243898
J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25114
pubmed: 30027583
AIDS Care. 2015;27(10):1298-303
pubmed: 26300297
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1287-90
pubmed: 26605986
Int J Cancer. 2016 Sep 15;139(6):1209-16
pubmed: 27098265
Lancet. 2012 Sep 8;380(9845):889-98
pubmed: 22901955
PLoS Med. 2015 Nov 24;12(11):e1001905; discussion e1001905
pubmed: 26599699
J Acquir Immune Defic Syndr. 2010 Mar;53(3):405-11
pubmed: 19745753
BMJ Open. 2018 Aug 23;8(8):e021506
pubmed: 30139898
S Afr Med J. 2014 Mar;104(3 Suppl 1):235-8
pubmed: 24893499
PLoS Med. 2018 Jun 11;15(6):e1002589
pubmed: 29889844
N Engl J Med. 2013 Oct 10;369(15):1385-7
pubmed: 24106930
Open Forum Infect Dis. 2014 Aug 12;1(2):ofu058
pubmed: 25734128
Int J Tuberc Lung Dis. 2015 Jan;19(1):104-10
pubmed: 25519799
PLoS One. 2013;8(2):e55308
pubmed: 23405133
J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):e64-71
pubmed: 23429504
J Acquir Immune Defic Syndr. 2015 May 1;69(1):e1-12
pubmed: 25942465
AIDS. 2011 Oct 23;25(16):2027-36
pubmed: 21997488
J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):383-389
pubmed: 28225717
J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e67-75
pubmed: 24977471
Trop Med Int Health. 2010 Jun;15 Suppl 1:1-15
pubmed: 20586956
BMC Health Serv Res. 2014 Aug 18;14:350
pubmed: 25134822
BMC Infect Dis. 2014 Aug 16;14:442
pubmed: 25129689
Lancet Glob Health. 2013 Dec;1(6):e319-20
pubmed: 25104588
Antivir Ther. 2014;19 Suppl 3:105-16
pubmed: 25310359
J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):429-32
pubmed: 21857353
Curr HIV/AIDS Rep. 2010 Nov;7(4):234-44
pubmed: 20820972
Lancet. 2010 Oct 9;376(9748):1244-53
pubmed: 20923715
BMC Health Serv Res. 2010 Aug 05;10:229
pubmed: 20687955
PLoS Med. 2011 Jul;8(7):e1001055
pubmed: 21811402
PLoS Med. 2010 Jun 22;7(6):e1000296
pubmed: 20582324

Auteurs

Ingrid V Bassett (IV)

Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Mingshu Huang (M)

Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.
Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.

Christie Cloete (C)

McCord Hospital, Durban, South Africa.

Sue Candy (S)

Department of Academic Affairs, Research and Quality Assurance, Corporate Data Warehouse, National Health Laboratory Services, Johannesburg, South Africa.

Janet Giddy (J)

McCord Hospital, Durban, South Africa.

Simone C Frank (SC)

Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Kenneth A Freedberg (KA)

Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Departments of Epidemiology and Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Elena Losina (E)

Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Departments of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Division of Rheumatology, Department of Medicine, and Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Rochelle P Walensky (RP)

Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Robert A Parker (RA)

Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH